{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-045526","form_type":"8-K","ticker":"NMRA","cik":"0001885522","company_name":"Neumora Therapeutics, Inc.","filed_at":"2026-02-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.677965+00:00","generated_at":"2026-05-16T03:23:13.689851+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Neumora Therapeutics releases corporate presentation at Guggenheim summit; no material details disclosed","bullets":["Presentation dated February 2026 made available for Guggenheim Emerging Outlook: Biotech Summit.","No financial results, pipeline updates, or guidance changes were provided in the filing.","The filing is a routine Regulation FD disclosure with limited substantive news."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-045526","json":"https://secwatch.observer/filing/0001193125-26-045526.json","markdown":"https://secwatch.observer/filing/0001193125-26-045526.md","text":"https://secwatch.observer/filing/0001193125-26-045526.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1885522/000119312526045526/0001193125-26-045526-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1885522/000119312526045526/nmra-20260211.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T03:23:13.689851+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}